Composition and therapeutic utility of conotoxins from genus Conus. Patent status 1996 - 2000
- 1 April 2001
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 11 (4) , 603-623
- https://doi.org/10.1517/13543776.11.4.603
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Synthetic Analogues of Conantokin-G: NMDA Antagonists Acting Through a Novel Polyamine-Coupled SiteJournal of Neurochemistry, 2002
- The Spasmodic Peptide Defines a New Conotoxin SuperfamilyBiochemistry, 2000
- Differential block of nicotinic synapses on B versus C neurones in sympathetic ganglia of frog byα-conotoxins MII and ImIBritish Journal of Pharmacology, 1997
- Presynaptic nicotinic ACh receptorsPublished by Elsevier ,1997
- (3SR,4aRS,6SR,8aRS)-6-(1H-Tetrazol-5-yl)decahydroisoquinoline-3-carboxylic Acid, a Novel, Competitive, Systemically Active NMDA and AMPA Receptor AntagonistJournal of Medicinal Chemistry, 1995
- α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cellsCell, 1994
- Serotonin release and cell proliferation are under the control of α‐bungarotoxin‐sensitive nicotinic receptors in small‐cell lung carcinoma cell linesFEBS Letters, 1994
- Excitatory amino acid receptors: A gallery of new targets for pharmacological interventionLife Sciences, 1994
- 6-Substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonistsJournal of Medicinal Chemistry, 1992
- .mu.-Conotoxin GIIIA, a peptide ligand for muscle sodium channels: chemical synthesis, radiolabeling and receptor characterizationBiochemistry, 1989